ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2026
The financial burden of prolonged urinary retention in patients awaiting holmium laser enucleation of the prostate in the Quebec healthcare system A retrospective cohort study.
Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWith rising surgical wait times for benign prostatic hyperplasia (BPH)-related urinary retention (UR), we aimed to assess the healthcare costs of prolonged UR management in patients awaiting holmium laser enucleation of the prostate (HoLEP) and evaluate the impact of wait times on resource utilization and complications.
methodsWe retrospectively analyzed 91 patients with BPH-related UR on the HoLEP waitlist (September 2021-2024). Wait times, urologic and emergency department (ED) visits, interventions, and costs were recorded. Total costs included institutional and physician-billed fees from our cost center. Continuous variables were reported as mean ± standard deviation or median (interquartile range).
resultsMean patient age was 71±8 years, with a mean prostate size of 123±54 g. Median wait time from retention to surgery was 220 days (149-300), with median total cost of $5315.95 (4343.85-7385.94). Longer wait times correlated with higher total costs (r=0.374, p<0.001) but inversely with cost per month (r=-0.680, p<0.001), suggesting cumulative burden over time. There were 685 urology clinic visits and 55 ED visits, nine (16%) resulting in hospital admissions. Complications occurred in 51 patients, including infections (63%), hematuria (47%), catheter issues (18%), and urosepsis (16%). Admissions were due to acute kidney injury (AKI) (n=3), urosepsis (n=2), pyelonephritis (n=2), and hematuria (n=2), with pyelonephritis, AKI, and urosepsis contributing the highest costs. Patients with complications required more visits and incurred higher costs (all p<0.05).
conclusionsProlonged UR management significantly increases healthcare costs. Prioritizing earlier surgical intervention may reduce complications, lessen economic strain, and improve patient outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.